These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37589128)

  • 21. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study.
    Costa L; Caso F; Del Puente A; Di Minno MN; Peluso R; Scarpa R
    J Rheumatol; 2016 Dec; 43(12):2149-2154. PubMed ID: 27633825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
    Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH
    Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates.
    Alnaqbi KA; Hannawi S; Namas R; Alshehhi W; Badsha H; Al-Saleh J
    Int J Rheum Dis; 2022 Oct; 25(10):1107-1122. PubMed ID: 35916205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Golimumab for the treatment of psoriatic arthritis.
    Yang H; Epstein D; Bojke L; Craig D; Light K; Bruce I; Sculpher M; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():87-95. PubMed ID: 21609657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
    Thibodaux RJ; Triche MW; Espinoza LR
    Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging drugs for psoriatic arthritis.
    Caso F; Del Puente A; Peluso R; Caso P; Girolimetto N; Del Puente A; Scarpa R; Costa L
    Expert Opin Emerg Drugs; 2016; 21(1):69-79. PubMed ID: 26807876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
    Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J
    Arthritis Rheumatol; 2019 Jan; 71(1):5-32. PubMed ID: 30499246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?
    Elalouf O; Chandran V
    Curr Rheumatol Rep; 2018 May; 20(7):36. PubMed ID: 29846825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study.
    Bavière W; Deprez X; Houvenagel E; Philippe P; Deken V; Flipo RM; Paccou J
    J Rheumatol; 2020 Mar; 47(3):369-376. PubMed ID: 31203223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of TNF inhibitors in psoriatic disease.
    Mandell BF; Sobell JM
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S64-8. PubMed ID: 25268598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
    Caso F; Cantarini L; Morisco F; Del Puente A; Ramonda R; Fiocco U; Lubrano E; Peluso R; Caso P; Galeazzi M; Punzi L; Scarpa R; Costa L
    Expert Opin Biol Ther; 2015 May; 15(5):641-50. PubMed ID: 25652590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approaches to biological therapy for psoriatic arthritis.
    Boyd T; Kavanaugh A
    Expert Opin Biol Ther; 2016; 16(2):173-86. PubMed ID: 26572089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity.
    Lories RJ; de Vlam K
    Expert Opin Biol Ther; 2014 Dec; 14(12):1825-36. PubMed ID: 25366335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal.
    Yang H; Craig D; Epstein D; Bojke L; Light K; Bruce IN; Sculpher M; Woolacott N
    Pharmacoeconomics; 2012 Apr; 30(4):257-70. PubMed ID: 22283690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments for new investigational JAK inhibitors in psoriatic arthritis.
    Caso F; Costa L; Triggianese P; Maione F; Bertolini N; Vastarella M; Chimenti MS; Tasso M
    Expert Opin Investig Drugs; 2023 May; 32(5):361-371. PubMed ID: 37096862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
    Haugeberg G; Michelsen B; Kavanaugh A
    RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.